Home > Press > Iran's Parto Negar Persia Company Files Patent in USPTO
Abstract:
Iran's Parto Negar Persia Company announced filing of a patent entitled 'Non-linear Filter for Medical Imaging' under the registration No 20120027274 in the United States Patent and Trademark Office (USPTO). The invention involves the creation of an algorithm to process the nuclear signals.
Iran's Parto Negar Persia Company Files Patent in USPTO
Tehran, Iran | Posted on June 16th, 2012The invention can improve the quality of devices used in nuclear medical imaging. The algorithm has also been used in HiReSPECT device, made by Parto Negar Persia Company.
Devices SPECT (Single Photon Emission Tomography) and PET (Positron Emission Tomography) are used in medical studies in order to follow nanodrugs in the bodies of laboratorial animals.
Parto Negar Persia Company, located in the Growth Center of Research Centre of Medical Devices of University of Tehran, is active in the field of designing and production of imaging devices. The company has benefited from the financial supports of Iran Nanotechnology Initiative Council to file its patent.
####
For more information, please click here
Copyright © Fars News Agency
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
| Related News Press |
Imaging
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Tools
Turning up the signal November 8th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||